US Stock MarketDetailed Quotes

PREVECEUTICAL MEDICAL INC (PRVCF)

Watchlist
  • 0.0097
  • 0.00000.00%
15min DelayTrading May 7 11:26 ET
5.69MMarket Cap-2.43P/E (TTM)

PREVECEUTICAL MEDICAL INC (PRVCF) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-365.65%-520.46K
-194.17%-560.68K
-78.64%-104.36K
-43.68%-426.69K
-77.28%-65.91K
-130.62%-111.77K
-64.49%-190.6K
38.80%-58.42K
-33.39%-296.97K
-116.29%-37.18K
Net income from continuing operations
-155.58%-858.12K
-246.68%-1.25M
-224.38%-763.59K
7.83%-1.17M
42.90%-241.57K
-40.11%-335.75K
-56.98%-361.96K
38.25%-235.4K
13.97%-1.27M
-226.71%-423.07K
Depreciation and amortization
42.01%3.61K
57.93%3.98K
28.01%3.2K
2.46%10.1K
3.55%2.54K
4.27%2.54K
1.65%2.52K
0.40%2.5K
-0.35%9.86K
-62.73%2.45K
Other non cash items
-12.26%76.31K
0.00%79.22K
-0.90%78.35K
3.07%318.47K
-7.72%73.21K
9.63%86.97K
3.50%79.22K
7.16%79.06K
-19.07%308.99K
127.95%79.34K
Change In working capital
58.45%213.06K
-8.58%81.93K
365.43%444.12K
-34.95%342.95K
-91.04%23.45K
26.17%134.47K
235.27%89.62K
-27.76%95.42K
6.53%527.21K
87.57%261.81K
-Change in receivables
79.15%-2.25K
333.04%21.89K
-4,082.76%-9.7K
-266.70%-21.85K
37.96%-1.43K
-1,024.38%-10.81K
-1,868.55%-9.39K
-101.69%-232
657.16%13.11K
-172.30%-2.3K
-Change in prepaid assets
164.94%10.73K
-842.58%-126.77K
-258.90%-22.85K
242.18%26.26K
-1.41%32.09K
28.28%-16.53K
147.28%17.07K
-178.26%-6.37K
31.48%-18.47K
249.47%32.55K
-Change in payables and accrued expense
26.44%204.58K
127.98%186.81K
367.23%476.67K
-36.43%338.54K
-103.12%-7.22K
25.96%161.8K
31.51%81.94K
-7.47%102.02K
1.60%532.57K
46.39%231.56K
Cash from discontinued investing activities
Operating cash flow
-365.65%-520.46K
-194.17%-560.68K
-78.64%-104.36K
-43.68%-426.69K
-77.28%-65.91K
-130.62%-111.77K
-64.49%-190.6K
38.80%-58.42K
-33.39%-296.97K
-116.29%-37.18K
Investing cash flow
Cash flow from continuing investing activities
42,671.09%54.49K
-1,389.41%-2.53K
-7,276.77%-57.47K
-1.8K
-722
-128
-105.18%-170
76.26%-779
0
0
Net PPE purchase and sale
--0
-1,641.18%-2.96K
--0
---1.8K
---722
---128
---170
---779
--0
--0
Net intangibles purchase and sale
--54.49K
--428
---57.47K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
42,671.09%54.49K
-1,389.41%-2.53K
-7,276.77%-57.47K
---1.8K
---722
---128
-105.18%-170
76.26%-779
--0
--0
Financing cash flow
Cash flow from continuing financing activities
429.80%592.21K
196.27%562.29K
80.20%108.91K
66.08%487.64K
237.75%125.63K
130.07%111.78K
75.74%189.79K
-39.47%60.44K
38.69%293.62K
-61.28%37.2K
Net issuance payments of debt
-240.92%-30.69K
-250.28%-126.22K
-2.53%58.91K
162.66%247.94K
119.73%81.73K
114.46%21.78K
-22.23%83.99K
-39.47%60.44K
-56.74%94.4K
-61.28%37.2K
Net common stock issuance
--542.09K
----
----
--94.7K
---11.1K
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
-10.21%80.81K
--0
--50K
-27.22%145K
--55K
--90K
--0
--0
--199.23K
--0
Cash from discontinued financing activities
Financing cash flow
429.80%592.21K
196.27%562.29K
80.20%108.91K
66.08%487.64K
237.75%125.63K
130.07%111.78K
75.74%189.79K
-39.47%60.44K
38.69%293.62K
-61.28%37.2K
Net cash flow
Beginning cash position
1,720.51%4.26K
94.77%5.48K
4,029.82%59.14K
-74.54%1.43K
-85.98%236
-90.68%234
-53.76%2.81K
-74.54%1.43K
-64.99%5.62K
-31.11%1.68K
Current changes in cash
107,085.59%126.24K
6.13%-918
-4,353.38%-52.91K
1,865.58%59.15K
327,672.22%59K
-197.52%-118
78.73%-978
12.27%1.24K
66.76%-3.35K
-99.99%18
Effect of exchange rate changes
-22,455.00%-26.83K
81.43%-297
-657.04%-752
-71.02%-1.44K
64.31%-96
112.64%120
-255.39%-1.6K
120.67%135
-131.96%-842
99.92%-269
End cash Position
43,830.93%103.68K
1,720.51%4.26K
94.77%5.48K
4,029.82%59.14K
4,029.82%59.14K
-85.98%236
-90.68%234
-53.76%2.81K
-74.54%1.43K
-74.54%1.43K
Free cash flow
-316.42%-465.96K
-195.24%-563.21K
-173.37%-161.82K
-44.29%-428.49K
-79.22%-66.63K
-130.88%-111.9K
-69.44%-190.77K
40.05%-59.2K
-33.39%-296.97K
-116.29%-37.18K
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -365.65%-520.46K-194.17%-560.68K-78.64%-104.36K-43.68%-426.69K-77.28%-65.91K-130.62%-111.77K-64.49%-190.6K38.80%-58.42K-33.39%-296.97K-116.29%-37.18K
Net income from continuing operations -155.58%-858.12K-246.68%-1.25M-224.38%-763.59K7.83%-1.17M42.90%-241.57K-40.11%-335.75K-56.98%-361.96K38.25%-235.4K13.97%-1.27M-226.71%-423.07K
Depreciation and amortization 42.01%3.61K57.93%3.98K28.01%3.2K2.46%10.1K3.55%2.54K4.27%2.54K1.65%2.52K0.40%2.5K-0.35%9.86K-62.73%2.45K
Other non cash items -12.26%76.31K0.00%79.22K-0.90%78.35K3.07%318.47K-7.72%73.21K9.63%86.97K3.50%79.22K7.16%79.06K-19.07%308.99K127.95%79.34K
Change In working capital 58.45%213.06K-8.58%81.93K365.43%444.12K-34.95%342.95K-91.04%23.45K26.17%134.47K235.27%89.62K-27.76%95.42K6.53%527.21K87.57%261.81K
-Change in receivables 79.15%-2.25K333.04%21.89K-4,082.76%-9.7K-266.70%-21.85K37.96%-1.43K-1,024.38%-10.81K-1,868.55%-9.39K-101.69%-232657.16%13.11K-172.30%-2.3K
-Change in prepaid assets 164.94%10.73K-842.58%-126.77K-258.90%-22.85K242.18%26.26K-1.41%32.09K28.28%-16.53K147.28%17.07K-178.26%-6.37K31.48%-18.47K249.47%32.55K
-Change in payables and accrued expense 26.44%204.58K127.98%186.81K367.23%476.67K-36.43%338.54K-103.12%-7.22K25.96%161.8K31.51%81.94K-7.47%102.02K1.60%532.57K46.39%231.56K
Cash from discontinued investing activities
Operating cash flow -365.65%-520.46K-194.17%-560.68K-78.64%-104.36K-43.68%-426.69K-77.28%-65.91K-130.62%-111.77K-64.49%-190.6K38.80%-58.42K-33.39%-296.97K-116.29%-37.18K
Investing cash flow
Cash flow from continuing investing activities 42,671.09%54.49K-1,389.41%-2.53K-7,276.77%-57.47K-1.8K-722-128-105.18%-17076.26%-77900
Net PPE purchase and sale --0-1,641.18%-2.96K--0---1.8K---722---128---170---779--0--0
Net intangibles purchase and sale --54.49K--428---57.47K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow 42,671.09%54.49K-1,389.41%-2.53K-7,276.77%-57.47K---1.8K---722---128-105.18%-17076.26%-779--0--0
Financing cash flow
Cash flow from continuing financing activities 429.80%592.21K196.27%562.29K80.20%108.91K66.08%487.64K237.75%125.63K130.07%111.78K75.74%189.79K-39.47%60.44K38.69%293.62K-61.28%37.2K
Net issuance payments of debt -240.92%-30.69K-250.28%-126.22K-2.53%58.91K162.66%247.94K119.73%81.73K114.46%21.78K-22.23%83.99K-39.47%60.44K-56.74%94.4K-61.28%37.2K
Net common stock issuance --542.09K----------94.7K---11.1K--0----------0--0
Proceeds from stock option exercised by employees -10.21%80.81K--0--50K-27.22%145K--55K--90K--0--0--199.23K--0
Cash from discontinued financing activities
Financing cash flow 429.80%592.21K196.27%562.29K80.20%108.91K66.08%487.64K237.75%125.63K130.07%111.78K75.74%189.79K-39.47%60.44K38.69%293.62K-61.28%37.2K
Net cash flow
Beginning cash position 1,720.51%4.26K94.77%5.48K4,029.82%59.14K-74.54%1.43K-85.98%236-90.68%234-53.76%2.81K-74.54%1.43K-64.99%5.62K-31.11%1.68K
Current changes in cash 107,085.59%126.24K6.13%-918-4,353.38%-52.91K1,865.58%59.15K327,672.22%59K-197.52%-11878.73%-97812.27%1.24K66.76%-3.35K-99.99%18
Effect of exchange rate changes -22,455.00%-26.83K81.43%-297-657.04%-752-71.02%-1.44K64.31%-96112.64%120-255.39%-1.6K120.67%135-131.96%-84299.92%-269
End cash Position 43,830.93%103.68K1,720.51%4.26K94.77%5.48K4,029.82%59.14K4,029.82%59.14K-85.98%236-90.68%234-53.76%2.81K-74.54%1.43K-74.54%1.43K
Free cash flow -316.42%-465.96K-195.24%-563.21K-173.37%-161.82K-44.29%-428.49K-79.22%-66.63K-130.88%-111.9K-69.44%-190.77K40.05%-59.2K-33.39%-296.97K-116.29%-37.18K
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More